Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
Elena Bolzacchini, Francesco Dentali(University of Insubria), Andrea Antonuzzo(Azienda Ospedaliera Universitaria Pisana), Luca Galli(University of Pisa), Sabrina Barzaghi(University of Insubria), Monica Giordano(Ospedale Sant'Anna), Salvatore Artale(Ospedale San Carlo), Martina Torchio(Azienda Socio Sanitaria Territoriale di Pavia), Lorenza Bertù(University of Insubria), Olga Nigro(Fondazione IRCCS Istituto Nazionale dei Tumori), Marco Bregni(Ospedale San Giuseppe), Marco Danova(Azienda Socio Sanitaria Territoriale di Pavia), Graziella Pinotti(Medica (Italy))
Cited by 6
Related Papers
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
|Journal of Clinical Oncology|2011|763
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684